1985
DOI: 10.1016/0167-8817(85)90002-1
|View full text |Cite
|
Sign up to set email alerts
|

Further characterisation of polyclonal antiserum for DNA photoproducts: the use of different labelled antigens to control its specificity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

3
16
0

Year Published

1986
1986
2010
2010

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(19 citation statements)
references
References 11 publications
3
16
0
Order By: Relevance
“…This property may reflect the occurrence of multiple photoproduct-specific excision enzymes, of which only one has reverted, or broad specificity in an excision enzyme complex (38) that has partially reverted allowing detection of only a few important lesions. The high immunogenicity of the (6-4) photoproduct supports the notion that this may be a more readily detectable lesion (20).…”
supporting
confidence: 57%
See 1 more Smart Citation
“…This property may reflect the occurrence of multiple photoproduct-specific excision enzymes, of which only one has reverted, or broad specificity in an excision enzyme complex (38) that has partially reverted allowing detection of only a few important lesions. The high immunogenicity of the (6-4) photoproduct supports the notion that this may be a more readily detectable lesion (20).…”
supporting
confidence: 57%
“…On the basis of this assay, the XP129 revertant and the parental XP12RO cell line both appear to be defective in the removal of cyclobutane dimers (Table 1), whereas the two normal cell lines removed about 60% of the initial number of dimers in 24 h. When repair of cyclobutane and (6-4)pyrimidinepyrimidone dimers was monitored by radioimmunoassays that specifically detect these lesions in DNA (18,20,21,36), slightly different results were obtained. Normal cells removed 50% of the cyclobutane dimers within 6 h of irradiation compared with none for XP12RO cells (Fig.…”
mentioning
confidence: 96%
“…Since Levine et al (17) first raised an antiserum against UV-irradiated single-stranded DNA and developed an immunological method for measuring DNA photoproducts using complement fixation in 1966, a number of other antisera have been prepared in many laboratories for DNA photoproduct measurement with some modifications (18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31). A polyvalent antiserum, however, may contain a heterogeneous population of antibodies that recognize various kinds of DNA damage (25,32,33). An immunological assay is an indirect method in which selective binding of an antibody to the corresponding antigen is essential and monoclonal antibodies are the most specific probes.…”
Section: Introductionmentioning
confidence: 99%
“…However, the very rapid removal of these binding sites and the lack of correlation with the kinetics of CPD‐specific UV endonuclease‐sensitive sites (14) were not consistent with what was known about the behavior of the CPD. RIA of pyrimidine homopolymers and alternating copolymers irradiated under different UV conditions eventually showed that the predominant binding site of polyclonal antisera raised against UV‐DNA was, in all probability, the (6‐4) PD (6,16,17). This immune response is probably predicated on the fact that the helical distortion of the (6‐4) PD elicited a significantly greater immune response in rabbits compared to the CPD and dominated the affinity of most antisera (see below).…”
Section: Antibody Production and Characterizationmentioning
confidence: 99%
“…These results were not consistent with the known repair kinetics using biochemical and enzymatic techniques. Subsequently, it was discovered that polyclonal antisera raised against heavily UV‐irradiated DNA contained multiple antibody populations predominated by the pyrimidine (6‐4) pyrimidone dimer [(6‐4) PD] (6). Combined with immunoassays created specifically for the cyclobutane pyrimidine dimer (CPD) it was shown that the (6‐4) PD was repaired much more rapidly than the CPD in “repair‐deficient” rodent cells (7).…”
mentioning
confidence: 99%